Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial-Reference-Cited by-同舟云学术

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial

Published:2023-10 Issue:10 Volume:10 Page:e640-e652
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Avihingsanon Anchalee,Lu Hongzhou,Leong Chee Loon,Hung Chien-Ching,Koenig Ellen,Kiertiburanakul Sasisopin,Lee Man-Po,Supparatpinyo Khuanchai,Zhang Fujie,Rahman Sophia,D'Antoni Michelle L,Wang Hongyuan,Hindman Jason T,Martin Hal,Baeten Jared M,Li Taisheng

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference27 articles.

1. Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis;Platt;J Viral Hepat,2020

2. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment;Singh;AIDS,2017

3. Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia;Vinikoor;Clin Infect Dis,2017

4. HBV/HIV coinfection: impact on the development and clinical treatment of liver diseases;Cheng;Front Med,2021

5. Functional cure of hepatitis B virus infection in individuals with HIV-coinfection: a literature review;Boyd;Viruses,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of tenofovir dipivoxil plus entecavir in patients with HBeAg positive chronic hepatitis B;Tropical Journal of Pharmaceutical Research;2024-09-06

2. Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study;The Lancet Gastroenterology & Hepatology;2024-08

3. Epidemiología, tratamiento y pronóstico de la infección VIH en 2024: revisión práctica;Medicina Clínica;2024-06

4. Epidemiology, treatment and prognosis of HIV infection in 2024: A practical review;Medicina Clínica (English Edition);2024-06

5. Evaluation of Pharmacokinetics of a BCS Class III Drug with Two Different Study Designs: Tenofovir Alafenamide Monofumarate Film-coated Tablet;AAPS PharmSciTech;2024-05-30